Tim Townes
13Patents
4h-index
9Co-inventors
53Inventor score
Filing activity: Jul 30, 1993 → Jun 17, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5602306A | Synthesis of functional human hemoglobin and other proteins in erythroid tissues of transgenic animals | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5864029A | Anti-sickling hemoglobin | Human Necessities | 5 | Expired |
| US9175311B2 | Polycistronic vector for human induced pluripotent stem cell production | Chemistry; Metallurgy | 4 | Active |
| US5877288A | Anti-sickling hemoglobin | Human Necessities | 4 | Expired |
| US5849688A | Transgenic,cross-linked hemoglobin | Human Necessities | 2 | Expired |
| US5766884A | Synthesis of functional human hemoglobin and other proteins in erythroid tissues of transgenic animals | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6306650A | Nucleic acid molecule encoding a .beta.-erythroid kruppel-like factor that binds to a .delta.-globin promoter | Chemistry; Metallurgy | 2 | Expired |
| US6022736A | Nucleic acid vectors comprising DNase I hypersensitive sites | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5610137A | Transgenic, cross-linked hemoglobin | Human Necessities | 0 | Expired |
| US6613957B1 | Synthesis of functional human hemoglobin and other proteins in erythroid tissues of transgenic non-human mammals | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6475740B2 | Method for identifying a &dgr;-eklf | Chemistry; Metallurgy | 0 | Expired |
| US11643668B2 | CRISPR/Cas9 complex for genomic editing | Chemistry; Metallurgy | 0 | Active |
| US11555207B2 | CRISPR/Cas9 complex for introducing a functional polypeptide into cells of blood cell lineage | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.